Cell & Gene Therapy

layoffs cut staff reduction workforce
Pharma

Bluebird bio lays off 25% of workforce

The layoff round means that nearly 100 bluebirds will have to leave the nest, with R&D and administration staffers bearing the brunt of the cuts.
Angus Liu Sep 24, 2024 10:19am
Lonza

Vertex adds CDMO Lonza to Casgevy production network

Sep 24, 2024 9:41am
Fosun

Gilead's Kite exits China cell therapy JV with Fosun Pharma

Sep 19, 2024 4:23pm
Ori IRO Charles River Jason Foster Matt Hewitt

Charles River looks to help bring Ori's CGT platform forward

Sep 18, 2024 8:01am
photo of a sign labeled closed on a business window

Astellas is closing down a gene therapy plant in California

Sep 4, 2024 12:46pm
layoffs

BioMarin lays off 225 more staffers under new corporate strategy

Aug 29, 2024 4:30am
More News

Headhunter lays out leadership goals for CDMO industry

Aug 14, 2024 10:51am

Legend CEO talks BIOSECURE Act, M&A rumor and Carvykti growth

Aug 9, 2024 10:30am

BioMarin downsizes gene therapy efforts to focus on 3 markets

Aug 6, 2024 10:34am

FDA signs off on first engineered cell therapy for a solid tumor

Aug 2, 2024 8:56am